Cargando…
Hit Generation in TB Drug Discovery: From Genome to Granuloma
[Image: see text] Current tuberculosis (TB) drug development efforts are not sufficient to end the global TB epidemic. Recent efforts have focused on the development of whole-cell screening assays because biochemical, target-based inhibitor screens during the last two decades have not delivered new...
Autores principales: | Yuan, Tianao, Sampson, Nicole S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832989/ https://www.ncbi.nlm.nih.gov/pubmed/29384369 http://dx.doi.org/10.1021/acs.chemrev.7b00602 |
Ejemplares similares
-
Correction to Hit Generation in TB Drug Discovery:
From Genome to Granuloma
por: Yuan, Tianao, et al.
Publicado: (2019) -
The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery
por: Yuan, Tianao, et al.
Publicado: (2021) -
Generation of Quality Hit Matter for Successful Drug Discovery Projects
por: Reynisson, Jóhannes
Publicado: (2019) -
HTS and hit finding in academia – from chemical genomics to drug discovery
por: Frearson, Julie A., et al.
Publicado: (2009) -
Human Granuloma In Vitro Model, for TB Dormancy and Resuscitation
por: Kapoor, Nidhi, et al.
Publicado: (2013)